Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:3226-3232
Published online before print August 6, 2009, doi: 10.1161/STROKEAHA.109.557967
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/10/3226    most recent
STROKEAHA.109.557967v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hug, A.
Right arrow Articles by Veltkamp, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hug, A.
Right arrow Articles by Veltkamp, R.
Related Collections
Right arrow Acute Cerebral Infarction

(Stroke. 2009;40:3226.)
© 2009 American Heart Association, Inc.


Original Contributions

Infarct Volume is a Major Determiner of Post-Stroke Immune Cell Function and Susceptibility to Infection

Andreas Hug, MD; Alexander Dalpke, MD; Nina Wieczorek; Thomas Giese, MD; Alexander Lorenz; Gerd Auffarth, MD; Arthur Liesz Roland Veltkamp, MD

From the Departments of Neurology (A.H., N.W., A.L., A.L., R.V.), Hygiene and Medical Microbiology (A.D.), and Ophthalmology (G.A.), and the Institute of Immunology (T.G.), University of Heidelberg, Germany.

Correspondence to Dr Andreas Hug, Department of Neurology, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany. E-mail andreas.hug{at}med.uni-heidelberg.de

Background and Purpose— Acute ischemic stroke in humans is associated with profound alterations in the immune system. Hallmarks of this stroke-induced immunodepression syndrome are: lymphocytopenia, impairment of T helper cell and monocyte function. We studied which stroke-specific factors predict these immunologic alterations and subsequent infections.

Methods— Leukocyte/lymphocyte subsets were assessed serially by white blood cell count and fluorescence-activated cell sorter analysis in ischemic stroke patients (n=50) at baseline, day 1, and day 4 after stroke onset and compared to an age-matched control group (n=40). Concomitantly, monocytic human leukocyte antigen-DR expression and the in vitro function of blood monocytes measured by the production of tumor necrosis factor-{alpha} upon stimulation with lipopolysaccharide were assessed. Associations of these immunologic parameters with stroke specific factors (National Institutes of Health Stroke Scale, infarct size) were explored. Multivariable logistic regression analysis was applied to identify early predictors for poststroke respiratory and urinary tract infections.

Results— Infarct volume was the main factor associated with lymphocytopenia on day 1 and day 4 poststroke. Particularly, blood natural killer cell counts were reduced after stroke. Monocyte counts increased after ischemia paralleled by a profound deactivation predominantly after extensive infarcts. Reduced T helper cell counts, monocytic human leukocyte antigen-DR expression, and monocytic in vitro production of tumor necrosis factor-{alpha} were associated with infections in univariate analyses. However, only stroke volume prevailed as independent early predictor for respiratory infections (OR 1.03; CI 1.01 to 1.04).

Conclusions— Infarct volume determines the extent of lymphocytopenia, monocyte dysfunction, and is a main predictor for subsequent infections.


Key Words: stroke • brain ischemia • immune system • leukocytes • mononuclear